×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EXAS – exact sciences corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EXAS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/12
06:02 am
exas
November $10B+ M&A Deals Set Q4 Up To Outpace Prior Quarter [Seeking Alpha]
Low
Report
November $10B+ M&A Deals Set Q4 Up To Outpace Prior Quarter [Seeking Alpha]
12/11
06:06 pm
exas
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS [Yahoo! Finance]
Neutral
Report
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS [Yahoo! Finance]
12/11
05:30 pm
exas
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
Low
Report
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
12/3
11:06 am
exas
Grail: Downgraded From Speculative Buy To Hold As The Stock Price Appreciated Faster Than Expected [Seeking Alpha]
Low
Report
Grail: Downgraded From Speculative Buy To Hold As The Stock Price Appreciated Faster Than Expected [Seeking Alpha]
11/28
07:01 pm
exas
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Stifel Nicolaus.
11/28
12:41 pm
exas
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
11/27
11:11 pm
exas
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN
Low
Report
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN
11/27
06:14 pm
exas
HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN
Low
Report
HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN
Date
Time
Symbol
Company Name
Action
%Chg
11/3/2025
04:05 pm
exas
exact sciences corporation
BEAT
Report
3.9%
exact sciences corporation
8/6/2025
04:05 pm
exas
exact sciences corporation
BEAT
Report
-8.0%
exact sciences corporation
5/1/2025
04:05 pm
exas
exact sciences corporation
MISS
Report
9.3%
exact sciences corporation
2/19/2025
04:05 pm
exas
exact sciences corporation
MISS
Report
-3.1%
exact sciences corporation
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/5
02:04 pm
exas
Form SCHEDULE 13G/A EXACT SCIENCES CORP Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A EXACT SCIENCES CORP Filed by: FMR LLC
11/26
04:01 pm
exas
Form DEFA14A EXACT SCIENCES CORP
Low
Report
Form DEFA14A EXACT SCIENCES CORP
11/24
10:19 am
exas
Form DEFA14A EXACT SCIENCES CORP
Low
Report
Form DEFA14A EXACT SCIENCES CORP
11/21
05:30 pm
exas
Form 4 EXACT SCIENCES CORP For: Nov 19 Filed by: Herriott James
Low
Report
Form 4 EXACT SCIENCES CORP For: Nov 19 Filed by: Herriott James
11/21
05:30 pm
exas
Form 4 EXACT SCIENCES CORP For: Nov 19 Filed by: ORVILLE JACOB A
Low
Report
Form 4 EXACT SCIENCES CORP For: Nov 19 Filed by: ORVILLE JACOB A
11/20
05:24 pm
exas
Form DEFA14A EXACT SCIENCES CORP
Low
Report
Form DEFA14A EXACT SCIENCES CORP
11/20
04:57 pm
exas
Form DEFA14A EXACT SCIENCES CORP
Low
Report
Form DEFA14A EXACT SCIENCES CORP
11/20
04:55 pm
exas
Form DEFA14A EXACT SCIENCES CORP
Low
Report
Form DEFA14A EXACT SCIENCES CORP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
Exact Sciences takes action during COVID-19 pandemic [Seeking Alpha]
37.6%
7/29 UPDATE 2-Diagnostic company Exact Sciences to buy Genomic Health in $2.8 bln deal [Reuters] 15.2%
4/3 Fulgent Genetics Is Fundamentally Sound [Seeking Alpha] 10.8%
4/16 2 Stocks That Could Double Your $1,200 Stimulus Check [The Motley Fool] 10.0%
4/8 Exact Sciences schedules first-quarter 2020 earnings call 7.2%
10/3 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 7.1%
11/8 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.6%
2/11 Form 8-K EXACT SCIENCES CORP For: Feb 11 6.5%
4/24 Form 3 EXACT SCIENCES CORP For: Apr 22 Filed by: Lewis-Hall Freda C 6.4%
10/14 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 6.0%
7/29 UPDATE 2-Diagnostic company Exact Sciences to buy Genomic Health in $2.8 bln deal [Reuters] 15.2%
4/3 Fulgent Genetics Is Fundamentally Sound [Seeking Alpha] 10.8%
4/16 2 Stocks That Could Double Your $1,200 Stimulus Check [The Motley Fool] 10.0%
4/8 Exact Sciences schedules first-quarter 2020 earnings call 7.2%
10/3 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 7.1%
11/8 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.6%
2/11 Form 8-K EXACT SCIENCES CORP For: Feb 11 6.5%
4/24 Form 3 EXACT SCIENCES CORP For: Apr 22 Filed by: Lewis-Hall Freda C 6.4%
10/14 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 6.0%
TOP News Decliners
3/14
EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.
-21.6%
1/12 Exact Sciences Announces Preliminary Fourth Quarter 2019 Results -13.8%
3/11 Why Exact Sciences, HealthEquity, and Senseonics Holdings Stocks Tanked Today [The Motley Fool] -12.7%
2/26 Exact Sciences to participate in March investor conferences -7.7%
3/3 Investors Should Revisit Exact Sciences Now [The Motley Fool] -7.5%
10/29 Q3/2019 9/30/2019 EPS -0.310 ZacksConsensus -0.410 ActVsEst 0.100 - Beat -7.3%
2/24 Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028 -6.9%
10/22 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.4%
8/2 Form 4 EXACT SCIENCES CORP For: Jul 31 Filed by: LEVANGIE DANIEL J -5.7%
9/23 EXACT Sciences Co. (NASDAQ: EXAS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. -5.4%
1/12 Exact Sciences Announces Preliminary Fourth Quarter 2019 Results -13.8%
3/11 Why Exact Sciences, HealthEquity, and Senseonics Holdings Stocks Tanked Today [The Motley Fool] -12.7%
2/26 Exact Sciences to participate in March investor conferences -7.7%
3/3 Investors Should Revisit Exact Sciences Now [The Motley Fool] -7.5%
10/29 Q3/2019 9/30/2019 EPS -0.310 ZacksConsensus -0.410 ActVsEst 0.100 - Beat -7.3%
2/24 Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028 -6.9%
10/22 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.4%
8/2 Form 4 EXACT SCIENCES CORP For: Jul 31 Filed by: LEVANGIE DANIEL J -5.7%
9/23 EXACT Sciences Co. (NASDAQ: EXAS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. -5.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: